Adverse drug reactions in the era of COVID-19

Excerpt

As I read the article by Crescioli et al. [1] entitled adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions, several thoughts came to mind. This article studied all reported COVID-19 medication adverse drug reactions in the COVID-19 units in a single center in Italy from January to May 2020. They collected data on 23 patients with reported COVID-19 treatment ADRs. These 23 patients were all Caucasian, 56% male and had a mean age over 76 years. This study showed that all patients were exposed to more than one suspected drug and 50% had more than 3 suspected medications. All but one patient had at least one drug–drug interaction. Almost 70% of patients were receiving more than 6 medications. …